Tags : Moberg

PharmaShots Weekly Snapshot (September 30–October 04, 2019)

1. Arbutus to Discontinue its P-Ia/Ib Clinical Study of AB-506 to Treat Patients with Chronic Hepatitis B Published: Oct 03, 2019 | Tags: Arbutus, Discontinue, P-Ia/Ib, Clinical Study, AB-506, Chronic Hepatitis B 2. Janssen’s Niraparib Receives the US FDA’s Breakthrough Therapy Designation for Metastatic Castration-Resistant Prostate Cancer Published: Oct 03, 2019 | Tags: Janssen, Niraparib, Receives, US, […]Read More